Carbon monoxide: Pro- or anti-angiogenic agent? Comment on Ahmad et al. (Thromb Haemost 2015; 113: 329-337)

Thrombosis and Haemostasis

Volumn 114, Issue 2, 2015, Pages 432-433

  Loboda, Agnieszka ^a   Jozkowicz, Alicja ^a   Dulak, Jozef ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; ENDOTHELIN; HEME OXYGENASE 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MICRORNA; MICRORNA 378; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; BIOLOGICAL ACTIVITY; CELL METABOLISM; CELL PROLIFERATION; CELL VIABILITY; INFLAMMATION; LETTER; NON SMALL CELL LUNG CANCER; PANCREAS ISLET CELL CARCINOMA; PANCREATIC STELLATE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; T LYMPHOCYTE; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; CHEMISTRY; HUMAN; METABOLISM; NEOVASCULARIZATION (PATHOLOGY);

ANIMALS; CARBON MONOXIDE; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84940100215     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH15-01-0082     Document Type: Letter

References (18)

1. Motterlini R, et al. Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res 2002; 90: 17-24.
2. Ahmad S, et al. Carbon monoxide inhibits sprouting angiogenesis and vascular endothelial growth factor receptor-2 phosphorylation. Thromb Hae-most 2015; 113: 329-337.
3. Deshane J, et al. Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-de-pendent mechanism. J Exp Med 2007; 204: 605-618.
4. Dulak J, et al. Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells. Antioxid Redox Signal 2002; 4: 229-240.
5. Jozkowicz A, et al. Heme oxygenase and angio-genic activity of endothelial cells: stimulation by carbon monoxide and inhibition by tin protopor-phyrin-IX. Antioxid Redox Signal 2003; 5: 155-162.
6. Vitek L, et al. Antiproliferative effects of carbon monoxide on pancreatic cancer. Dig Liver Dis 2014; 46: 369-375.
7. Motterlini R, et al. CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule. FASEB J 2005; 19: 284-286.
8. Wegiel B, et al. Nitric oxide-dependent bone marrow progenitor mobilization by carbon monoxide enhances endothelial repair after vascular injury. Circulation 2010; 121: 537-548.
9. Otterbein LE, et al. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 2003; 9: 183-190.
10. Schwer CI, et al. Carbon monoxide releasing mol-ecule-2 inhibits pancreatic stellate cell proliferation by activating p38 mitogen-activated protein kinase/heme oxygenase-1 signaling. Mol Pharmacol 2010; 77: 660-669.
11. Song R, et al. Carbon monoxide inhibits T lymphocyte proliferation via caspase-dependent pathway. J Immunol 2004; 172: 1220-1226.
12. Skrzypek K, et al. Interplay between heme oxyge-nase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis. Antioxid Redox Signal 2013; 19: 644-660.
13. Was H, et al. Overexpression of heme oxygenase-1 in murine melanoma: increased proliferation and viability of tumor cells, decreased survival of mice. Am J Pathol 2006; 169: 2181-2198.
14. Reiter CE, Alayash AI. Effects of carbon monoxide (CO) delivery by a CO donor or hemoglobin on vascular hypoxia inducible factor 1alpha and mitochon-drial respiration. FEBS Open Bio 2012; 2: 113-118.
15. Choi YK, et al. Carbon monoxide promotes VEGF expression by increasing HIF-1alpha protein level via two distinct mechanisms, translational activation and stabilization of HIF-1alpha protein. J Biol Chem 2010; 285: 32116-32125.
16. Wegiel B, et al. The social network of carbon monoxide in medicine. Trends Mol Med 2013; 19: 3-11.
17. Li Volti G, et al. Carbon monoxide signaling in promoting angiogenesis in human microvessel en-dothelial cells. Antioxid Redox Signal 2005; 7: 704-710.
18. Ahanger AA, et al. Wound healing activity of carbon monoxide liberated from CO-releasing molecule (CO-RM). Naunyn Schmiedebergs Arch Pharmacol 2011; 384: 93-102.